- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
弱势下跌过程中，可逢高卖出，暂不考虑买进。
- 中期趋势：
正处于反弹阶段。
- 长期趋势：
已有57家主力机构披露2024-12-31报告期持股数据，持仓量总计14.44亿股，占流通A股44.15%
- 波段诊断：
-
技术面诊股
诊断结果：5.6技术面打败了34%的股票
技术面评分前10的股票
近期的平均成本为2.17元。空头行情中，目前正处于反弹阶段，投资者可适当关注。
平均成本
近期的平均成本为2.17元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"2.17","date":1752739197,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑输行业平均水平。
[{"date":"2025.07.18","stock":"0.93","trade":"-0.07","ind":"0.37"},{"date":"2025.07.17","stock":"0.93","trade":"2.96","ind":"1.43"},{"date":"2025.07.16","stock":"0.47","trade":"0.13","ind":"-0.22"},{"date":"2025.07.15","stock":"-1.84","trade":"-0.79","ind":"0.56"},{"date":"2025.07.14","stock":"-1.81","trade":"0.81","ind":"-0.11"},{"date":"2025.07.11","stock":"0.91","trade":"2.01","ind":"0.61"},{"date":"2025.07.10","stock":"1.86","trade":"0.43","ind":"0.47"},{"date":"2025.07.09","stock":"0.47","trade":"1.30","ind":"-0.06"},{"date":"2025.07.08","stock":"2.39","trade":"2.54","ind":"1.46"},{"date":"2025.07.07","stock":"-3.69","trade":"-0.90","ind":"-0.70"},{"date":"2025.07.04","stock":"-1.36","trade":"0.02","ind":"-0.25"},{"date":"2025.07.03","stock":"-0.45","trade":"0.81","ind":"1.17"},{"date":"2025.07.02","stock":"-0.90","trade":"-1.49","ind":"-0.61"},{"date":"2025.07.01","stock":"1.36","trade":"1.25","ind":"0.11"},{"date":"2025.06.30","stock":"-1.79","trade":"3.53","ind":"0.83"},{"date":"2025.06.27","stock":"-0.44","trade":"1.43","ind":"0.34"},{"date":"2025.06.26","stock":"-0.44","trade":"-1.05","ind":"-0.48"},{"date":"2025.06.25","stock":"0.00","trade":"0.45","ind":"1.72"},{"date":"2025.06.24","stock":"0.00","trade":"1.52","ind":"1.68"},{"date":"2025.06.23","stock":"0.44","trade":"1.79","ind":"0.43"},{"date":"2025.06.20","stock":"-0.44","trade":"-0.53","ind":"-0.47"}]
新里程,深证成指,医疗服务指数
压力支撑
该股压力位为2.17元，支撑位为2.14元。
[{"text":"\u538b\u529b\u4f4d","value":"2.17","date":1752768000,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"2.14","date":1752768000,"color":"0x0b52a1"}]
多空趋势
空头行情中，目前正处于反弹阶段，投资者可适当关注。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：2.1资金面打败了5%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：07月18日 20:31
| 机构今日流向(万元) | -1970.07 | 机构5日流向(万元) | -2793.64 |
| 机构10日流向(万元) | -3932.34 | 机构20日流向(万元) | -6468.43 |
机构持仓
2024-12-31 与 2024-06-30 相比，主力机构持仓量减少15761.48万股，其中基金净增仓1家，主力净减仓6家，暂未发现中长期投资价值。
截止2024-12-31，共57家主力机构（基金50家，券商1家，一般法人6家），持仓量总计144449.88万股，占流通A股44.15%
其中，基金持仓与2024-06-30相比：
增仓：10家 ，增持 1420.63万股
减仓：9家 ，减持 100.91万股
新出现在主力名单中：31家 ，持有1501万股
从主力名单中消失：37家 ，原持有18582.2万股
其中，基金持仓与2024-06-30相比：
增仓：10家 ，增持 1420.63万股
减仓：9家 ，减持 100.91万股
新出现在主力名单中：31家 ，持有1501万股
从主力名单中消失：37家 ，原持有18582.2万股
消息面诊股
诊断结果：4.7消息面打败了9%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 新里程：7月17日获融资买入651.98万元，占当
2025-07-18 - 新里程：7月16日获融资买入1169.60万元，占
2025-07-17 - 新里程：7月14日获融资买入1113.96万元
2025-07-15 - 新里程：盱眙县中医院评审结果预计7月底前取得评审结
2025-07-15 - 新里程：7月11日获融资买入761.07万元，占当
2025-07-14 - 医疗集团董事长被留置立案调查！3万张床位、2.2万
2025-07-11 - 新里程：7月10日获融资买入859.50万元，占当
2025-07-11 - 爱心人寿大股东董事长被立案，医养融合战略或面临变数
2025-07-10 - 新里程：现任新里程健康科技集团股份有限公司代理董事
2025-07-10 - 新里程：7月9日获融资买入1440.60万元，占当
2025-07-10
消息列表
| 一般消息 | 高管变动 | 实施留置并立案调查 | 2025-07-04 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2025-06-20 |
| 一般消息 | 股东大会 | 年度股东大会 | 2025-04-29 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-04-29 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-25 |
| 一般消息 | 资产重组 | 公司股权转让 | 2024-12-24 |
| 一般消息 | 重大事项 | 关联交易 | 2024-12-12 |
| 一般消息 | 分红转增 | 不分配不转增 | 2024-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2024-08-21 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 1条 | 0条 | 1条 |
行业面诊股
诊断结果：7.7行业面打败了98%的股票
医疗服务行业最新资金流向
近10日来该行业走势明显向上，跑赢大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势明显向上，跑赢大盘。
[{"date":"2025.07.18","price":"0.37","value":"-0.07"},{"date":"2025.07.17","price":"1.43","value":"2.96"},{"date":"2025.07.16","price":"-0.22","value":"0.13"},{"date":"2025.07.15","price":"0.56","value":"-0.79"},{"date":"2025.07.14","price":"-0.11","value":"0.81"},{"date":"2025.07.11","price":"0.61","value":"2.01"},{"date":"2025.07.10","price":"0.47","value":"0.43"},{"date":"2025.07.09","price":"-0.06","value":"1.30"},{"date":"2025.07.08","price":"1.46","value":"2.54"},{"date":"2025.07.07","price":"-0.70","value":"-0.90"},{"date":"2025.07.04","price":"-0.25","value":"0.02"},{"date":"2025.07.03","price":"1.17","value":"0.81"},{"date":"2025.07.02","price":"-0.61","value":"-1.49"},{"date":"2025.07.01","price":"0.11","value":"1.25"},{"date":"2025.06.30","price":"0.83","value":"3.53"},{"date":"2025.06.27","price":"0.34","value":"1.43"},{"date":"2025.06.26","price":"-0.48","value":"-1.05"},{"date":"2025.06.25","price":"1.72","value":"0.45"},{"date":"2025.06.24","price":"1.68","value":"1.52"},{"date":"2025.06.23","price":"0.43","value":"1.79"},{"date":"2025.06.20","price":"-0.47","value":"-0.53"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | *ST生物 | 74.03% | 3.19% | 6.6分 |
| 2 | 成都先导 | 44.60% | 28.55% | 6.3分 |
| 3 | 昭衍新药 | 42.20% | 2.31% | 6.7分 |
| 4 | 皓元医药 | 31.54% | 1.31% | 6.5分 |
| 5 | 诚达药业 | 29.60% | 12.58% | 6.1分 |
| 6 | 博腾股份 | 29.43% | -0.94% | 6.0分 |
| 8 | 海特生物 | 27.52% | 13.42% | 6.4分 |
| 10 | 药康生物 | 26.32% | 2.10% | 5.7分 |
| 12 | 和元生物 | 24.79% | 1.67% | 5.8分 |
| 14 | 泓博医药 | 23.82% | 4.61% | 6.7分 |
| 16 | 药石科技 | 22.77% | 4.82% | 5.6分 |
| 18 | 阳光诺和 | 21.21% | 8.57% | 7.0分 |
| 20 | 凯莱英 | 20.33% | 0.83% | 6.0分 |
| 22 | 九洲药业 | 16.42% | 0.00% | 6.3分 |
| 24 | 康龙化成 | 14.85% | -2.74% | 6.2分 |
| 26 | 兰卫医学 | 13.25% | 1.79% | 5.9分 |
| 28 | 金凯生科 | 12.31% | -2.58% | 6.0分 |
| 30 | 百诚医药 | 11.41% | -1.22% | 5.1分 |
| 32 | 华厦眼科 | 9.87% | 1.81% | 6.6分 |
| 34 | 盈康生命 | 9.52% | 1.42% | 6.3分 |
| 36 | 三博脑科 | 8.10% | 1.08% | 5.3分 |
| 38 | 华大基因 | 7.17% | 3.00% | 5.3分 |
| 40 | 爱尔眼科 | 5.48% | 0.00% | 6.3分 |
| 42 | 睿智医药 | 4.29% | 2.76% | 6.1分 |
| 44 | 新里程 | -3.11% | -1.36% | 5.2分 |
| 46 | 光正眼科 | -46.14% | 1.52% | 5.3分 |
| 48 | - | - | 153.01% | 分 |
| 50 | 奥浦迈 | - | 3.21% | 5.6分 |
| 52 | 创新医疗 | - | 0.07% | 6.1分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2025-03-31 ]公司经营
盈利能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 21/100 ， 37/100。
[{"date":"2025-03-31","value":"1.28","vol":"0.92"},{"date":"2024-12-31","value":"5.89","vol":"-0.15"},{"date":"2024-09-30","value":"2.62","vol":"3.24"},{"date":"2024-06-30","value":"2.99","vol":"2.52"},{"date":"2024-03-31","value":"1.26","vol":"1.10"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
1.28 | 5.89 | 2.62 | 2.99 | 1.26 |
| 行业(%) | 0.92 | -0.15 | 3.24 | 2.52 | 1.10 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"27.96","vol":"34.67"},{"date":"2024-12-31","value":"30.93","vol":"34.77"},{"date":"2024-09-30","value":"28.69","vol":"36.16"},{"date":"2024-06-30","value":"29.06","vol":"36.37"},{"date":"2024-03-31","value":"28.80","vol":"36.30"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
27.96 | 30.93 | 28.69 | 29.06 | 28.80 |
| 行业(%) | 34.67 | 34.77 | 36.16 | 36.37 | 36.30 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 41/100 ， 33/100。
[{"date":"2025-03-31","value":"-16.49","vol":"-0.08"},{"date":"2024-12-31","value":"-2.95","vol":"-0.73"},{"date":"2024-09-30","value":"6.93","vol":"0.87"},{"date":"2024-06-30","value":"12.20","vol":"0.65"},{"date":"2024-03-31","value":"9.85","vol":"3.42"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-16.49 | -2.95 | 6.93 | 12.20 | 9.85 |
| 行业(%) | -0.08 | -0.73 | 0.87 | 0.65 | 3.42 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"-9.35","vol":"-25.93"},{"date":"2024-12-31","value":"296.13","vol":"-96.53"},{"date":"2024-09-30","value":"57.98","vol":"-161.08"},{"date":"2024-06-30","value":"5.27","vol":"-107.95"},{"date":"2024-03-31","value":"12.19","vol":"-51.89"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-9.35 | 296.13 | 57.98 | 5.27 | 12.19 |
| 行业(%) | -25.93 | -96.53 | -161.08 | -107.95 | -51.89 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 17/100 ， 16/100。
[{"date":"2025-03-31","value":"0.12","vol":"0.10"},{"date":"2024-12-31","value":"0.59","vol":"0.41"},{"date":"2024-09-30","value":"0.43","vol":"0.31"},{"date":"2024-06-30","value":"0.29","vol":"0.20"},{"date":"2024-03-31","value":"0.14","vol":"0.10"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.12 | 0.59 | 0.43 | 0.29 | 0.14 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.20 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.90","vol":"3.76"},{"date":"2024-12-31","value":"12.47","vol":"16.35"},{"date":"2024-09-30","value":"8.99","vol":"14.25"},{"date":"2024-06-30","value":"5.99","vol":"8.86"},{"date":"2024-03-31","value":"2.74","vol":"4.59"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
2.90 | 12.47 | 8.99 | 5.99 | 2.74 |
| 行业(次) | 3.76 | 16.35 | 14.25 | 8.86 | 4.59 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2025-03-31","value":"-4.77","vol":"-1.69"},{"date":"2024-12-31","value":"22.91","vol":"22.34"},{"date":"2024-09-30","value":"4.39","vol":"12.23"},{"date":"2024-06-30","value":"13.96","vol":"9.92"},{"date":"2024-03-31","value":"1.27","vol":"0.21"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -4.77 | 22.91 | 4.39 | 13.96 | 1.27 |
| 行业 | -1.69 | 22.34 | 12.23 | 9.92 | 0.21 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"","vol":"0.00"},{"date":"2024-12-31","value":"1.26","vol":"1.31"},{"date":"2024-09-30","value":"","vol":"0.00"},{"date":"2024-06-30","value":"1.69","vol":"1.44"},{"date":"2024-03-31","value":"","vol":"0.00"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 1.26 | - | 1.69 | - |
| 行业 | 0.00 | 1.31 | 0.00 | 1.44 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 31/100 ， 9/100。
[{"date":"2025-03-31","value":"0.60","vol":"3.84"},{"date":"2024-12-31","value":"0.57","vol":"3.70"},{"date":"2024-09-30","value":"0.58","vol":"4.11"},{"date":"2024-06-30","value":"0.60","vol":"4.14"},{"date":"2024-03-31","value":"0.59","vol":"4.40"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
0.60 | 0.57 | 0.58 | 0.60 | 0.59 |
| 行业 | 3.84 | 3.70 | 4.11 | 4.14 | 4.40 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"0.53","vol":"3.12"},{"date":"2024-12-31","value":"0.50","vol":"3.01"},{"date":"2024-09-30","value":"0.51","vol":"3.38"},{"date":"2024-06-30","value":"0.53","vol":"3.39"},{"date":"2024-03-31","value":"0.51","vol":"3.62"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
0.53 | 0.50 | 0.51 | 0.53 | 0.51 |
| 行业 | 3.12 | 3.01 | 3.38 | 3.39 | 3.62 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 16/100 ， 4/100。
[{"date":"2025-03-31","value":"69.06","vol":"32.24"},{"date":"2024-12-31","value":"69.44","vol":"32.31"},{"date":"2024-09-30","value":"65.53","vol":"31.03"},{"date":"2024-06-30","value":"66.24","vol":"31.65"},{"date":"2024-03-31","value":"68.28","vol":"31.05"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
69.06 | 69.44 | 65.53 | 66.24 | 68.28 |
| 行业(%) | 32.24 | 32.31 | 31.03 | 31.65 | 31.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2025-03-31","value":"2.29","vol":"0.98"},{"date":"2024-12-31","value":"2.34","vol":"1.01"},{"date":"2024-09-30","value":"1.94","vol":"0.85"},{"date":"2024-06-30","value":"2.00","vol":"0.87"},{"date":"2024-03-31","value":"2.19","vol":"0.92"}]
| 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
2.29 | 2.34 | 1.94 | 2.00 | 2.19 |
| 行业(%) | 0.98 | 1.01 | 0.85 | 0.87 | 0.92 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 首创证券 | 2025-05-08 | 买入 | |
| 湘财证券 | 2025-05-08 | 买入 | |
| 国投证券 | 2025-05-05 | 买入 |
机构预测
机构预测该股2025年每股收益与前一年相同，长期投资价值一般。
[{"date":"2021","yellowRectValue":"-3.71","blueLineValue":"","type":""},{"date":"2022","yellowRectValue":"1.56","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.29","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"1.15","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"1.51","blueLineValue":"0.05","type":"YC"}]